Brainstorm Cell Therapeutics Inc  

(Public, OTCBB:BCLI)   Watch this stock  
Find more results for OTC:BCLI
+0.005 (1.96%)
Apr 17 - Close
OTCBB data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.25 - 0.26
52 week 0.10 - 0.37
Open 0.25
Vol / Avg. 244,809.00/947,606.00
Mkt cap 45.04M
P/E     -
Div/yield     -
EPS -0.03
Shares 176.26M
Beta 0.74
Inst. own 6%

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -89.26% -97.63%
Return on average equity -134.21% -145.78%
Employees 15 -
CDP Score - -


NEW YORK, NY 10158
United States - Map
+1-646-6663188 (Phone)
+1-302-6555049 (Fax)

Website links


BrainStorm Cell Therapeutics Inc. is a biotechnology company developing autologous stem cell therapies for highly debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson�s disease (PD) and Spinal Cord Injury. These diseases have limited treatment options and as such represent unmet medical needs. NurOwn is BrainStorm�s process for the propagation and differentiation of adult, autologous Mesenchymal Stem Cells (MSC) into NeuroTrophic Factor (NTF)-secreting cells, and the transplantation of these specialized cells at or near the affected tissue site. NurOwn offers the hope of repairing degenerated tissues and curing the underlying pathology, rather than treating its symptoms. BrainStorm is conducting clinical trials with NurOwn in ALS patients. In February 2011, the United States Food and Drug Administration (FDA) granted Orphan Drug designation to NurOwn for the treatment of ALS.

Officers and directors

Abraham Israeli Independent Chairman of the Board
Age: 59
Chaim Lebovits President, Principal Executive Officer
Age: 42
Liat Sossover Chief Financial Officer
Age: 44
Adrian Harel Ph.D. Director - Research and Development
Age: 56
Irit Arbel Independent Director
Age: 53
Mordechai Friedman Independent Director
Age: 61
Alon Pinkas Independent Director
Age: 51
Chen Schor CPA Independent Director
Age: 41
Robert G. Shorr Ph.D. Independent Director
Age: 59